These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25436983)

  • 1. EphrinB1: novel microtubule associated protein whose expression affects taxane sensitivity.
    Colbert PL; Vermeer DW; Wieking BG; Lee JH; Vermeer PD
    Oncotarget; 2015 Jan; 6(2):953-68. PubMed ID: 25436983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers.
    Vermeer PD; Bell M; Lee K; Vermeer DW; Wieking BG; Bilal E; Bhanot G; Drapkin RI; Ganesan S; Klingelhutz AJ; Hendriks WJ; Lee JH
    PLoS One; 2012; 7(1):e30447. PubMed ID: 22279592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
    Cai P; Lu P; Sharom FJ; Fang WS
    Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
    Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
    PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression.
    Heuer TS; Ventura R; Mordec K; Lai J; Fridlib M; Buckley D; Kemble G
    EBioMedicine; 2017 Feb; 16():51-62. PubMed ID: 28159572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the structures of taxane derivatives and their microtubule polymerization activity.
    Hidaka M; Koga T; Kiyota H; Horiguchi T; Shi QW; Hirose K; Uchida T
    Biosci Biotechnol Biochem; 2012; 76(2):349-52. PubMed ID: 22313785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.
    Matesanz R; Trigili C; Rodríguez-Salarichs J; Zanardi I; Pera B; Nogales A; Fang WS; Jímenez-Barbero J; Canales A; Barasoain I; Ojima I; Díaz JF
    Bioorg Med Chem; 2014 Sep; 22(18):5078-90. PubMed ID: 25047938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphrinB1 interacts with the transcriptional co-repressor Groucho/xTLE4.
    Kamata T; Bong YS; Mood K; Park MJ; Nishanian TG; Lee HS
    BMB Rep; 2011 Mar; 44(3):199-204. PubMed ID: 21429299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer.
    Cassinelli G; Lanzi C; Supino R; Pratesi G; Zuco V; Laccabue D; Cuccuru G; Bombardelli E; Zunino F
    Clin Cancer Res; 2002 Aug; 8(8):2647-54. PubMed ID: 12171897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of C7 substitutions in a high affinity microtubule-binding taxane on antitumor activity and drug transport.
    Xiao X; Wu J; Trigili C; Chen H; Chu JW; Zhao Y; Lu P; Sheng L; Li Y; Sharom FJ; Barasoain I; Diaz JF; Fang WS
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4852-6. PubMed ID: 21764308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral interaction: a possible contributing factor in head and neck cancer progression.
    Underbrink MP; Hoskins SL; Pou AM; Albrecht T
    Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.
    Taraboletti G; Micheletti G; Rieppi M; Poli M; Turatto M; Rossi C; Borsotti P; Roccabianca P; Scanziani E; Nicoletti MI; Bombardelli E; Morazzoni P; Riva A; Giavazzi R
    Clin Cancer Res; 2002 Apr; 8(4):1182-8. PubMed ID: 11948131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical aspects of microtubule bundling in taxane-treated circulating tumor cells.
    Kim M; Rejniak KA
    Biophys J; 2014 Sep; 107(5):1236-1246. PubMed ID: 25185559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers.
    Wang R; Wang H; Wang Z
    J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lx2-32c, a novel taxane and its antitumor activities in vitro and in vivo.
    Wang H; Li H; Zuo M; Zhang Y; Liu H; Fang W; Chen X
    Cancer Lett; 2008 Sep; 268(1):89-97. PubMed ID: 18482796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells.
    Fujita Y; Kojima T; Kawakami K; Mizutani K; Kato T; Deguchi T; Ito M
    Prostate; 2015 Oct; 75(14):1568-78. PubMed ID: 26074357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line.
    Ragin CC; Reshmi SC; Gollin SM
    Int J Cancer; 2004 Jul; 110(5):701-9. PubMed ID: 15146560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pocket similarity identifies selective estrogen receptor modulators as microtubule modulators at the taxane site.
    Lo YC; Cormier O; Liu T; Nettles KW; Katzenellenbogen JA; Stearns T; Altman RB
    Nat Commun; 2019 Mar; 10(1):1033. PubMed ID: 30833575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesyltransferase inhibitors reverse taxane resistance.
    Marcus AI; O'Brate AM; Buey RM; Zhou J; Thomas S; Khuri FR; Andreu JM; Díaz F; Giannakakou P
    Cancer Res; 2006 Sep; 66(17):8838-46. PubMed ID: 16951201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.
    Roque DM; Bellone S; Buza N; Romani C; Cocco E; Bignotti E; Ravaggi A; Rutherford TJ; Schwartz PE; Pecorelli S; Santin AD
    Am J Obstet Gynecol; 2013 Jul; 209(1):62.e1-9. PubMed ID: 23583215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.